General manager of ChinaPeptides, Wang Xiping discussed the investment cooperation with Dr Lee who is from bio Wuhan Biolake Industrial Development, reached an initial agreement. ChinaPeptides will invest the Biolake, to establish a new peptide production base in Wuhan. The project is expected to complete by the end of 2011, it will become the large peptide production and development base in central China.